Compounds > 17 alpha-hydroxyprogesterone caproate
Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Abnormalities, Drug-Induced

17 alpha-hydroxyprogesterone caproate has been researched along with Abnormalities, Drug-Induced in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klinger, G; Merlob, P; Stahl, B1
DECECCO, C; LOJODICE, G; VENTO, R1
Czeizel, AE; Dudás, I; Gidai, J1
Brent, RL; Calda, P; Christian, MS1
Morsman, J; Varma, TR1
Johnson, CK; Nelson, GW; Seegmiller, RE1
Brent, RL; Carbone, JP1
Binkerd, P; Günzel, P; Hendrickx, AG; Korte, R; Leuschner, F; Neumann, BW; Poggel, A; Prahalada, S1
Bruen, JA; Hick, JF; Kurland, LT; Noller, KL; O'Fallon, WM; Resseguie, LJ1

Reviews

2 review(s) available for 17 alpha-hydroxyprogesterone caproate and Abnormalities, Drug-Induced

ArticleYear
17α Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Reproductive toxicology (Elmsford, N.Y.), 2012, Volume: 33, Issue:1

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Animals; Cost Savings; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Evidence-Based Medicine; Female; Gestational Age; Humans; Hydroxyprogesterones; Injections; Pregnancy; Premature Birth; Recurrence; Risk Assessment; Risk Factors

2012
Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2007, Volume: 20, Issue:2

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Abortion, Spontaneous; Animals; Drug Compounding; Hydroxyprogesterones; Premature Birth; Progesterone Congeners; Progestins; Stillbirth

2007

Other Studies

7 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Abnormalities, Drug-Induced

ArticleYear
[FEMALE PSEUDOHERMAPHRODITISM PROBABLY INDUCED BY A PROGESTINIC ADMINISTERED INTRAMUSCULARLY: 17-ALPHA-HYDROXYPROGESTERONE CAPRONATE].
    Minerva pediatrica, 1964, Sep-15, Volume: 16

    Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; 46, XX Disorders of Sex Development; Abnormalities, Drug-Induced; Abortion, Threatened; Disorders of Sex Development; Female; Humans; Hydroxyprogesterones; Infant; Infant, Newborn; Pregnancy; Progestins; Toxicology

1964
Population-based case-control teratogenic study of hydroxyprogesterone treatment during pregnancy.
    Congenital anomalies, 2006, Volume: 46, Issue:4

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Case-Control Studies; Female; Gestational Age; Humans; Hungary; Hydroxyprogesterones; Infant, Newborn; Male; Pregnancy; Registries; Retrospective Studies; Risk Factors; Teratogens

2006
Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1982, Volume: 20, Issue:1

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Corpus Luteum Maintenance; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Infertility, Female; Outcome and Process Assessment, Health Care; Pregnancy; Prenatal Exposure Delayed Effects

1982
Evaluation of the teratogenic potential of delalutin (17 alpha-hydroxyprogesterone caproate) in mice.
    Teratology, 1983, Volume: 28, Issue:2

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Animals; Body Weight; Dose-Response Relationship, Drug; Female; Fetal Resorption; Hydroxyprogesterones; Muridae; Pregnancy; Progestins; Sex Factors; Tretinoin

1983
Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1/6J mouse.
    American journal of obstetrics and gynecology, 1993, Volume: 169, Issue:5

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Animals; Cartilage; Embryonic and Fetal Development; Female; Genitalia; Hydroxyprogesterones; Mice; Mice, Inbred C57BL; Osteogenesis; Prenatal Care; Progestins

1993
Embryotoxicity of sex steroidal hormones in nonhuman primates: II. Hydroxyprogesterone caproate, estradiol valerate.
    Teratology, 1987, Volume: 35, Issue:1

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Abortion, Veterinary; Animals; Drug Combinations; Estradiol; Female; Fetal Death; Fetal Resorption; Gestational Age; Hydroxyprogesterones; Macaca fascicularis; Macaca mulatta; Maternal-Fetal Exchange; Pregnancy

1987
Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.
    Fertility and sterility, 1985, Volume: 43, Issue:4

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Ethisterone; Female; Fetal Death; Humans; Hydroxyprogesterones; Infant, Newborn; Male; Maternal-Fetal Exchange; Medroxyprogesterone; Minnesota; Norethindrone; Pregnancy; Prenatal Exposure Delayed Effects; Progesterone; Progestins

1985